Artelo Biosciences financial statements
아르텔로 바이오사이언시스NASDAQ:ARTL · Nasdaq · Healthcare$3.68-3.92%
2026-10-02 closeArtelo Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$10M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy